Literature DB >> 11742148

Effects of acamprosate on sensitization to the locomotor-stimulant effects of alcohol in mice selectively bred for high and low alcohol preference.

J A Chester1, N J Grahame, T K Li, L Lumeng, J C Froehlich.   

Abstract

Sensitization to the locomotor-stimulant effects of drugs is thought to play an important role in the development of drug-seeking behaviour. We hypothesized that the ability of acamprosate to reduce alcohol relapse rates in recovering alcoholics, and alcohol consumption in rodents, may be related to its ability to reduce sensitization to the locomotor-stimulant effects of alcohol. The purpose of the present study was to determine whether acamprosate reduces the expression of sensitization to the locomotor-stimulant effects of alcohol in lines of mice selectively bred for high (HAP) and low (LAP) alcohol preference. Mice were given six intraperitoneal (i.p.) injections of alcohol (3 g/kg) or saline at 48 h intervals. The test for sensitization to the locomotor-stimulant effects of alcohol consisted of a challenge dose of 2 g/kg i.p. alcohol followed immediately by assessment of locomotor activity for 20 min. Mice were pretreated with either saline or acamprosate (400 mg/kg) at 14 h and again at 2 h before the alcohol challenge. Both HAP and LAP mice showed sensitization to the locomotor-stimulant effects of alcohol. Acamprosate reduced the expression of sensitization to the locomotor-stimulant effects of alcohol in HAP but not LAP mice. These data suggest complex effects of acamprosate on alcohol-stimulated locomotor activity that depend on genotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742148     DOI: 10.1097/00008877-200111000-00015

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  5 in total

1.  Intragastric self-infusion of ethanol in high- and low-drinking mouse genotypes after passive ethanol exposure.

Authors:  T L Fidler; A M Dion; M S Powers; J J Ramirez; J A Mulgrew; P J Smitasin; A T Crane; C L Cunningham
Journal:  Genes Brain Behav       Date:  2010-12-16       Impact factor: 3.449

2.  Fluoxetine, desipramine, and the dual antidepressant milnacipran reduce alcohol self-administration and/or relapse in dependent rats.

Authors:  Emmanuelle Simon O'Brien; Rémi Legastelois; Hakim Houchi; Catherine Vilpoux; Stéphanie Alaux-Cantin; Olivier Pierrefiche; Etienne André; Mickaël Naassila
Journal:  Neuropsychopharmacology       Date:  2011-03-23       Impact factor: 7.853

3.  Effects of acamprosate on neuronal receptors and ion channels expressed in Xenopus oocytes.

Authors:  Matthew T Reilly; Ingrid A Lobo; Lindsay M McCracken; Cecilia M Borghese; Diane Gong; Takafumi Horishita; R Adron Harris
Journal:  Alcohol Clin Exp Res       Date:  2008-02       Impact factor: 3.455

4.  The CUL3/neddylation inhibitor MLN4924 reduces ethanol-induced locomotor sensitization and inflammatory pain allodynia in mice.

Authors:  Zhong Ding; Gregory T Knipp; Richard M van Rijn; Julia A Chester; Val J Watts
Journal:  Behav Brain Res       Date:  2020-12-03       Impact factor: 3.332

Review 5.  Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.

Authors:  Elizabeth M Burnette; Steven J Nieto; Erica N Grodin; Lindsay R Meredith; Brian Hurley; Karen Miotto; Artha J Gillis; Lara A Ray
Journal:  Drugs       Date:  2022-02-08       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.